Yoya Georges Koumba, Bedos-Belval Florence, Constant Patricia, Duran Hubert, Daffé Mamadou, Baltas Michel
Université de Toulouse, UPS, LSPCMIB (Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique), 118, Route de Narbonne, F-31062 Toulouse Cedex 9, France.
Bioorg Med Chem Lett. 2009 Jan 15;19(2):341-3. doi: 10.1016/j.bmcl.2008.11.082. Epub 2008 Nov 27.
In an effort to develop potent new antituberculous drugs effective against Mycobacterium tuberculosis, we have prepared series of cinnamic derivatives (thioesters and amides) with 4-hydroxy and 4-alkoxy groups and investigated the in vitro activities of these compounds. Among them some displayed a good in vitro antibacterial activity, such as (E)-N-(2-acetamidoethyl)-3-{4-[(E)-3,7-dimethylocta-2,6-dienyloxy]phenyl}acrylamide 4b that showed a minimum inhibitory concentration of 0.1microg/mL (0.26microM) against M. tuberculosis H37Rv.
为了开发对结核分枝杆菌有效的新型强效抗结核药物,我们制备了一系列带有4-羟基和4-烷氧基的肉桂酸衍生物(硫酯和酰胺),并研究了这些化合物的体外活性。其中一些表现出良好的体外抗菌活性,例如(E)-N-(2-乙酰氨基乙基)-3-{4-[(E)-3,7-二甲基辛-2,6-二烯氧基]苯基}丙烯酰胺4b对结核分枝杆菌H37Rv的最低抑菌浓度为0.1μg/mL(0.26μM)。